| 查看: 763 | 回复: 0 | |||
ienjoysun银虫 (著名写手)
|
[交流]
FDA Releases Draft Guidance on Using the Inactive Ingredient Database
|
|
FDA Releases Draft Guidance on Using the Inactive Ingredient Database The draft guidance provides industry with a guide for using the database to assist in the development of drug products. Jul 10, 2019 By Pharmaceutical Technology Editors On July 10, 2019, FDA published draft guidance for public comment on the use of the Inactive Ingredient Database (IID). The guidance document provides information on how to use the IID when choosing inactive ingredients in the development of new drug products. The guidance also supports the agency’s efforts in the promotion of generic drugs as part of its Drug Competition Action Plan. The guidance also describes how the agency uses the IID to support the safety of inactive ingredients. It describes the structure of the IID, the process for adding ingredients to the IID, and how information is presented in the database, which gives users a better understanding of how to use the information. The IDD lists information on inactive ingredients used in FDA-approved drug products. Once an inactive ingredient is used in an approved drug for a specific route of administration it is not considered novel; therefore, the ingredient may not require extensive review by the agency the next time it is used in a new product. Source: FDA |
回复此楼» 猜你喜欢
中山大学-第七医院-招科研助理1名（基因设计和克隆、RNA合成）
已经有1人回复
-
巴黎萨克雷大学与国家留学基金委合作博士研究生项目-脂质纳米药物/生物材料/多酚递送
已经有10人回复
-
药物学论文润色/翻译怎么收费?
已经有210人回复
-
292药学调剂
已经有1人回复
-
锦州医科大学药用生物材料（专业代码1007Z1）招收调剂考生
已经有0人回复
-
锦州医科大学药用生物材料（专业代码1007Z1）招收调剂考生
已经有2人回复
-
26申博自荐
已经有12人回复
-
SUES&NERCN课题组接受硕士生调剂 (学硕1名+专硕1名)
已经有0人回复
-
SUES&NERCN课题组接受硕士生调剂 (学硕1名+专硕1名)
已经有0人回复
-
SUES&NERCN课题组接受硕士生调剂 (学硕1名+专硕1名)
已经有0人回复
-
求大佬收留
已经有0人回复